Sarah B. Noonberg's Net Worth
$225 Thousand
Who is Sarah B. Noonberg?
Sarah B. Noonberg does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Prothena Corp plc, Protagonist Therapeutics, Inc, Neoleukin Therapeutics, Inc., and MARINUS PHARMACEUTICALS, INC..
SEC CIK
Sarah B. Noonberg's CIK is 0001706301
Past Insider Trading and Trends
2021 was Sarah B. Noonberg's most active year for acquiring shares with 4 total transactions. Sarah B. Noonberg's most active month to acquire stocks was the month of April. 2021 was Sarah B. Noonberg's most active year for disposing of shares, totalling 5 transactions. Sarah B. Noonberg's most active month to dispose stocks was the month of January. 2021 saw Sarah B. Noonberg paying a total of $58,632.00 for 51,400 shares, this is the most they've acquired in one year. In 2021 Sarah B. Noonberg cashed out on 16,800 shares for a total of $212,555.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Prothena Corp plc (PRTA) Snapshot price: $26.63
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Protagonist Therapeutics, Inc (PTGX) Snapshot price: $25.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
$16.14 | -$153,923.00 |
0
|
Scheduled
|
Feb 10 - Feb 11
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Neurogene Inc. (NLTX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MARINUS PHARMACEUTICALS, INC. (MRNS) Snapshot price: $9.94
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +19.49% | 2.3K |
—
|
—
| 14.1K |
Jun 18
| |||
Form 4
| +63.89% | 4.6K |
—
|
—
| 11.8K |
Jan 18
| |||
Form 4
|
∞
| 7.2K |
—
|
—
| 7.2K |
May 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Metagenomi, Inc. No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +135.56% | 57.76K |
—
|
—
| 100.37K |
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||